124 related articles for article (PubMed ID: 19801690)
1. Outcome of inoperable hepatocellular carcinoma patients receiving transarterial chemoembolisation: a real-life retrospective analysis in a Hong Kong regional hospital.
Yip WM; Hung HG; Lok KH; Li KF; Li KK; Szeto ML
Hong Kong Med J; 2009 Oct; 15(5):339-45. PubMed ID: 19801690
[TBL] [Abstract][Full Text] [Related]
2. Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: a multivariate analysis of prognostic factors.
Mondazzi L; Bottelli R; Brambilla G; Rampoldi A; Rezakovic I; Zavaglia C; Alberti A; Idèo G
Hepatology; 1994 May; 19(5):1115-23. PubMed ID: 7513677
[TBL] [Abstract][Full Text] [Related]
3. [Chemoembolization in hepatocellular carcinoma: multivariate analysis of survival prognostic factors after the first session].
El Khaddari S; Gaudin JL; Abidi H; Picaud G; Rode A; Souquet JC
Gastroenterol Clin Biol; 2002; 26(8-9):728-34. PubMed ID: 12434077
[TBL] [Abstract][Full Text] [Related]
4. Validation of the SNACOR clinical scoring system after transarterial chemoembolisation in patients with hepatocellular carcinoma.
Mähringer-Kunz A; Weinmann A; Schmidtmann I; Koch S; Schotten S; Pinto Dos Santos D; Pitton MB; Dueber C; Galle PR; Kloeckner R
BMC Cancer; 2018 Apr; 18(1):489. PubMed ID: 29703174
[TBL] [Abstract][Full Text] [Related]
5. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial.
Llovet JM; Real MI; Montaña X; Planas R; Coll S; Aponte J; Ayuso C; Sala M; Muchart J; Solà R; Rodés J; Bruix J;
Lancet; 2002 May; 359(9319):1734-9. PubMed ID: 12049862
[TBL] [Abstract][Full Text] [Related]
6. Transarterial chemoembolization for huge hepatocellular carcinoma with diameter over ten centimeters: a large cohort study.
Xue T; Le F; Chen R; Xie X; Zhang L; Ge N; Chen Y; Wang Y; Zhang B; Ye S; Ren Z
Med Oncol; 2015 Mar; 32(3):64. PubMed ID: 25682389
[TBL] [Abstract][Full Text] [Related]
7. Radiological response predicts survival following transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma.
Kim DY; Ryu HJ; Choi JY; Park JY; Lee DY; Kim BK; Kim SU; Ahn SH; Chon CY; Han KH
Aliment Pharmacol Ther; 2012 Jun; 35(11):1343-50. PubMed ID: 22486716
[TBL] [Abstract][Full Text] [Related]
8. Transarterial chemoembolization for inoperable, early stage hepatocellular carcinoma in patients with Child-Pugh grade A and B: results of a comparative study in 96 Chinese patients.
Yuen MF; Chan AO; Wong BC; Hui CK; Ooi GC; Tso WK; Yuan HJ; Wong DK; Lai CL
Am J Gastroenterol; 2003 May; 98(5):1181-5. PubMed ID: 12809846
[TBL] [Abstract][Full Text] [Related]
9. Superselective transarterial chemoembolization for hepatocellular carcinoma. Validation of treatment algorithm proposed by Japanese guidelines.
Takayasu K; Arii S; Kudo M; Ichida T; Matsui O; Izumi N; Matsuyama Y; Sakamoto M; Nakashima O; Ku Y; Kokudo N; Makuuchi M
J Hepatol; 2012 Apr; 56(4):886-92. PubMed ID: 22173160
[TBL] [Abstract][Full Text] [Related]
10. Treatment of hepatocellular carcinoma in Child-Pugh B patients.
Piscaglia F; Terzi E; Cucchetti A; Trimarchi C; Granito A; Leoni S; Marinelli S; Pini P; Bolondi L
Dig Liver Dis; 2013 Oct; 45(10):852-8. PubMed ID: 23582346
[TBL] [Abstract][Full Text] [Related]
11. Rationality and effectiveness of transarterial chemoembolization as an initial treatment for BCLC B stage HBV-related hepatocellular carcinoma.
Heng-jun G; Yao-jun Z; Min-shan C; Mei-xian C; Jun-ting H; Li X; Lau WY
Liver Int; 2014 Apr; 34(4):612-20. PubMed ID: 24028297
[TBL] [Abstract][Full Text] [Related]
12. Superselective Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma: Rationale, Technique, and Outcome.
Miyayama S; Matsui O
J Vasc Interv Radiol; 2016 Sep; 27(9):1269-1278. PubMed ID: 27345337
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma: high hepatitis B viral load and mortality in patients treated with transarterial chemoembolization.
Yu SJ; Lee JH; Jang ES; Cho EJ; Kwak MS; Yoon JH; Lee HS; Kim CY; Kim YJ
Radiology; 2013 May; 267(2):638-47. PubMed ID: 23440326
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes of transcatheter arterial chemoembolization with autologous blood clot for unresectable hepatocellular carcinoma.
Gunji T; Kawauchi N; Akahane M; Watanabe K; Kanamori H; Ohnishi S
Int J Oncol; 2002 Aug; 21(2):427-32. PubMed ID: 12118341
[TBL] [Abstract][Full Text] [Related]
15. Treatment of hepatocellular carcinoma using transarterial chemoembolization: a real-life, single-centre study from Southern Brazil.
Lionço LC; de Mattos AA; Horbe AF; Costabeber AM; de Mattos ÂZ; Tarasconi DP
Eur J Gastroenterol Hepatol; 2017 Feb; 29(2):225-230. PubMed ID: 27759574
[TBL] [Abstract][Full Text] [Related]
16. Chemoembolization for hepatocellular carcinoma: multivariate analysis of predicting factors for tumor response and survival in a 362-patient cohort.
Hu HT; Kim JH; Lee LS; Kim KA; Ko GY; Yoon HK; Sung KB; Gwon DI; Shin JH; Song HY
J Vasc Interv Radiol; 2011 Jul; 22(7):917-23. PubMed ID: 21571545
[TBL] [Abstract][Full Text] [Related]
17. Treatment outcomes of transcatheter arterial chemoembolization for hepatocellular carcinoma that invades hepatic vein or inferior vena cava.
Chung SM; Yoon CJ; Lee SS; Hong S; Chung JW; Yang SW; Seong NJ; Jang ES; Kim JW; Jeong SH
Cardiovasc Intervent Radiol; 2014 Dec; 37(6):1507-15. PubMed ID: 24464259
[TBL] [Abstract][Full Text] [Related]
18. Chemoembolization with cisplatin, lipiodol and Gelfoam and subsequent systemic chemotherapy with cisplatin and interferon in patients with hepatocellular carcinoma: a non-randomized prospective study.
Baur M; Walter R; Gebauer A; Tscholakoff D; Lochs H; Mühlbacher F; Turetschek K; Binder R; Hudec M; Gangl A; Ferenci P; Dittrich C
Int J Oncol; 2003 Sep; 23(3):811-9. PubMed ID: 12888922
[TBL] [Abstract][Full Text] [Related]
19. Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma.
O'Suilleabhain CB; Poon RT; Yong JL; Ooi GC; Tso WK; Fan ST
Br J Surg; 2003 Mar; 90(3):325-31. PubMed ID: 12594668
[TBL] [Abstract][Full Text] [Related]
20. Transcatheter arterial chemoembolization with doxorubicin-eluting superabsorbent polymer microspheres in the treatment of hepatocellular carcinoma: midterm follow-up.
Dekervel J; van Malenstein H; Vandecaveye V; Nevens F; van Pelt J; Heye S; Laleman W; Van Steenbergen W; Vaninbroukx J; Verslype C; Maleux G
J Vasc Interv Radiol; 2014 Feb; 25(2):248-55.e1. PubMed ID: 24295569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]